Aaron P Tansy, MD
- ASSISTANT PROFESSOR | Neurology
Aaron Tansy, MD is an Assistant Professor of Neurology at the Mount Sinai Medical Center and Director of the Stroke Program at Mount Sinai Queens. He received a BA with honors from Washington University in St. Louis and a MD from Case Western Reserve University.
Dr. Tansy completed an internship at Metrohealth Medical Center/Case Western Reserve University, a neurology residency at Columbia University, and a vascular neurology fellowship at UCLA. He is board certified in Adult Neurology with subspecialty certification in Vascular Neurology.
Dr. Tansy centers his practice on patients with stroke, and has clinical interests within hyperacute ischemic stroke and non-atherosclerotic causes of stroke. His research interests include imaging, telemedicine, and non-medical therapeutic applications in hyperacute stroke. Dr. Tansy is a site investigator at Mt. Sinai for multiple national and international clinical trials of stroke. He has authored multiple peer-reviewed journal articles, reviews, and book chapters. In addition, Dr. Tansy serves on the editorial board for Frontiers in Neurocritical and Neurohospitalist Care and as an ad-hoc reviewer for peer-reviewed medical journals.
Neurology, American Board of Psychiatry and Neurology
MD, Case Western Reserve University
Internship, Internal Medicine, MetroHealth Medical Center
Residency, Neurology, Columbia University Medical Center
Fellowship, Neurovascular, UCLA Medical Center
- Multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven, superiority phase III study of secondary prevention of stroke and prevention of systemic embolism in patients with a recent Embolic Stroke of Undetermined Source (ESUS), comparing rivaroxaban 15 mg once daily with aspirin 100 mg (NAVIGATE ESUS)
This is a multicenter, randomized, double blind, double-dummy, active-compactor, event driven, superiority phase III study of secondary prevention of stroke and prevention of systematic embolism in patient with a recent Embolic Stroke of Undetermined Source (ESUS). The study w...
- A Phase IIIb, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Alteplase in Patients with Mild Stroke: Rapidly Improving Symptoms and Minor Neurological Deficits (PRISMS)
This is a double blind, multicenter, randomized, phase IIIB, study to evaluate the efficacy and safety of Intravenous alteplase in Acute Ischemic stroke (AIS) in patients with mild ischemic strokes (also known as "minor neurologic deficit" and "rapidly improving stroke symptom...
Tarpley J, Franc D, Tansy AP, Liebeskind DS. Use of perfusion imaging and other imaging techniques to assess risks/benefits of acute stroke interventions. Current atherosclerosis reports 2013 Jul; 15(7).
Corbetta M, Tansy AP, Stanley CM, Astafiev SV, Snyder AZ, Shulman GL. A functional MRI study of preparatory signals for spatial location and objects. Neuropsychologia 2005; 43(14).
Shulman GL, McAvoy MP, Cowan MC, Astafiev SV, Tansy AP, d'Avossa G, Corbetta M. Quantitative analysis of attention and detection signals during visual search. Journal of neurophysiology 2003 Nov; 90(5).
Shulman GL, d'Avossa G, Tansy AP, Corbetta M. Two attentiona